Valuation: MedCap AB

Market Cap 8.03B 811M 721M 668M 608M 1.15B 77B 1.17B 3.15B 40.18B 3.04B 2.98B 128B P/E 2026 *
32.4x
P/E 2027 * 27.2x
Enterprise Value 8.12B 820M 729M 675M 615M 1.16B 77.81B 1.18B 3.18B 40.61B 3.08B 3.01B 129B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 2.93x
Free-Float
88.3%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week+4.17%
Current month+2.39%
1 month+0.47%
3 months+4.38%
6 months+3.97%
Current year-2.28%
1 week 526
Extreme 526
543.5
1 month 499.2
Extreme 499.2
544.5
Current year 440
Extreme 440
582
1 year 440
Extreme 440
636
3 years 247
Extreme 247
677
5 years 135
Extreme 135
677
10 years 27
Extreme 27
677
Manager TitleAgeSince
Chief Executive Officer 50 2020-10-31
Director of Finance/CFO 52 2020-04-29
Corporate Officer/Principal 54 2019-12-31
Director TitleAgeSince
Chairman 52 2007-12-31
Director/Board Member 63 2022-04-30
Director/Board Member 66 2022-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Buy 1,500 0.0099%
2/9/26
Anders Larnholt Forvaltning AB
SellCompany 1,500 0.0099%
2/6/26 Sell 500 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+4.17%-3.33%+109.16% 811M
+1.21%+4.80%-2.31%+83.95% 175B
+0.53%-0.68%+30.88%+79.97% 147B
+0.85%+0.41%+35.21%+232.10% 96.43B
-2.37%-6.72%-31.80%+4.21% 85.28B
-0.96%-2.23%-16.84%+76.73% 81.7B
-1.62%-5.21%-26.69%+48.77% 77.39B
-1.84%-2.26%-15.65%+48.10% 72.31B
-1.12%-5.28%+48.80%+141.47% 45.21B
-0.35%+0.06%+6.50%+54.78% 44.24B
Average -0.44%-1.29%+2.48%+87.92% 82.6B
Weighted average by Cap. -0.28%-0.94%+3.32%+86.76%

Financials

2026 *2027 *
Net sales 2.4B 242M 215M 200M 182M 343M 22.99B 348M 940M 11.99B 909M 890M 38.24B 2.69B 271M 241M 224M 203M 384M 25.75B 390M 1.05B 13.44B 1.02B 997M 42.84B
Net income 256M 25.8M 22.93M 21.26M 19.34M 36.49M 2.45B 37.08M 100M 1.28B 96.82M 94.76M 4.07B 317M 32.01M 28.45M 26.37M 23.99M 45.28M 3.04B 46M 124M 1.59B 120M 118M 5.05B
Net Debt 85M 8.58M 7.63M 7.07M 6.43M 12.14M 815M 12.34M 33.33M 425M 32.21M 31.53M 1.36B -148M -14.99M -13.33M -12.35M -11.24M -21.21M -1.42B -21.55M -58.22M -743M -56.28M -55.08M -2.37B
Projected Income Statement - Annual - MedCap AB
Logo MedCap AB
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Employees
647
Date Price Change Volume
26-10-16 SEK 536.50 +1.23% 11,986
26-10-15 SEK 530.00 -1.30% 14,355
26-10-14 SEK 537.00 +1.80% 12,932
26-10-13 SEK 527.50 0.00% 10,251
26-10-12 SEK 527.50 +2.43% 20,275
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
MarketScreener Ratings - MedCap AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
536.50SEK
Average target price
640.00SEK
Spread / Average Target
+19.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MedCap AB
  1. Stock Market
  2. Stocks
  3. MCAP Stock